Efficacy and Safety of USL for Dry Eye Disease

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Dry Eye Disease
Interventions
DRUG

USL

500mg of Achyranthis Radix Extract

DRUG

USL Placebo

USL Placebo

All Listed Sponsors
lead

Chan-Sik Kim

OTHER_GOV